University Hospital of Zurich
The University Hospital of Zürich is one of five university hospitals in Switzerland.
The first hospital in Zürich, from which the current hospital derives, is recorded as having existed as early as 1204. The name, location and buildings have since changed many times., the hospital employs an approximate staff of 8,000 providing medical care to 134,000 ambulant and over 35,000 stationary patients each year in 42 clinics.
Scientists and physicians of international renown who have practiced at the hospital include Ferdinand Sauerbruch, Andreas Grüntzig and Rolf M. Zinkernagel; the latter received a Nobel Prize for research done at the hospital.
History
In 1996, the University Hospital of Zurich’s dermatology department developed an approach using dendritic cells to vaccinate patients with advanced melanoma.In 2020, the hospital co-led a large-scale international study with Harvard Medical School on the use of the antimalarial drugs hydroxychloroquine and chloroquine for COVID-19 treatment. The research, published in The Lancet, found no clinical benefit and reported a higher mortality rate among patients who received the drugs. However, the study was retracted shortly afterward due to concerns about the reliability of the underlying data, which had been provided by an external company. The hospital later clarified that it had not participated in the data collection or analysis and had joined the project only during the evaluation phase.